Molcure Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
37
- Latest Deal Type
-
2ndary - Private
- Investors
-
8
Molcure General Information
Description
Developer of a bio-pharmaceutical technology intended to assist in drug discovery. The company's services offer users knowledge of next-generation sequencing, bioinformatics, and antibody biology with an automated discovery system, enabling pharmaceutical companies to reduce research and development time.
Contact Information
Website
www.molcure.comCorporate Office
- Airbic A07, 7-7 Shinkawasaki
- Saiwai-ku, Kawasaki-shi, Kanagawa
- Kawasaki, Kanagawa 212-0032
- Japan
Corporate Office
- Airbic A07, 7-7 Shinkawasaki
- Saiwai-ku, Kawasaki-shi, Kanagawa
- Kawasaki, Kanagawa 212-0032
- Japan
Molcure Timeline
Molcure Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Secondary Transaction - Private | 01-Dec-2021 | Completed | Generating Revenue | |||
6. Later Stage VC (Series C) | 17-Aug-2021 | Completed | Generating Revenue | |||
5. Accelerator/Incubator | 01-Dec-2019 | Completed | Generating Revenue | |||
4. Later Stage VC | 27-Nov-2018 | Completed | Generating Revenue | |||
3. Early Stage VC (Series A) | 27-Sep-2014 | Completed | Generating Revenue | |||
2. Seed Round | 01-Jun-2013 | $100K | $211K | Completed | Generating Revenue | |
1. Debt - General | 07-Feb-2013 | $110K | $110K | Completed | Generating Revenue |
Molcure Patents
Molcure Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-10962548-B2 | Method for determining and system for determining polypeptide bonding to target molecule | Active | 22-Nov-2013 | ||
JP-6338235-B2 | Screening method and production method of low molecular weight antibody | Active | 22-Nov-2013 | ||
US-20160291032-A1 | Method for determining and system for determining polypeptide bonding to target molecule | Active | 22-Nov-2013 | ||
JP-6465407-B2 | Method and system for determining a polypeptide that binds to a target molecule | Active | 22-Nov-2013 | ||
JP-6665274-B2 | Method and system for determining polypeptide binding to target molecule | Active | 22-Nov-2013 | G01N33/6818 |
Molcure Signals
Molcure Investors (8)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Jafco | Venture Capital | Minority | ||
Japan Post Capital | Venture Capital | Minority | ||
SBI Investment | Corporate Venture Capital | Minority | ||
STRIVE (VC Investor) | Corporate Venture Capital | Minority | ||
Plug and Play Tech Center | Accelerator/Incubator | Minority |
Molcure FAQs
-
When was Molcure founded?
Molcure was founded in 2013.
-
Where is Molcure headquartered?
Molcure is headquartered in Kawasaki, Japan.
-
What is the size of Molcure?
Molcure has 37 total employees.
-
What industry is Molcure in?
Molcure’s primary industry is Drug Discovery.
-
Is Molcure a private or public company?
Molcure is a Private company.
-
What is Molcure’s current revenue?
The current revenue for Molcure is
. -
How much funding has Molcure raised over time?
Molcure has raised $12M.
-
Who are Molcure’s investors?
Jafco, Japan Post Capital, SBI Investment, STRIVE (VC Investor), and Plug and Play Tech Center are 5 of 8 investors who have invested in Molcure.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »